Brain Control of Plasma Cholesterol Involves Polysialic Acid Molecules in the Hypothalamus

Frontiers in Neuroscience
Xavier BrenachotAlexandre Benani

Abstract

The polysialic acid (PSA) is a large glycan that is added to cell-surface proteins during their post-translational maturation. In the brain, PSA modulates distances between cells and controls the plasticity of the nervous system. In the hypothalamus, PSA is involved in many aspects of energy balance including food intake, osmoregulation, circadian rhythm, and sleep. In this work, we investigated the role of hypothalamic PSA in the regulation of plasma cholesterol levels and distribution. We report that HFD consumption in mice rapidly increased plasma cholesterol, including VLDL, LDL, and HDL-cholesterol. Although plasma VLDL-cholesterol was normalized within the first week, LDL and HDL were still elevated after 2 weeks upon HFD. Importantly, we found that hypothalamic PSA removal aggravated LDL elevation and reduced HDL levels upon HFD. These results indicate that hypothalamic PSA controls plasma lipoprotein profile by circumventing the rise of LDL-to-HDL cholesterol ratio in plasma during overfeeding. Although mechanisms by which hypothalamic PSA controls plasma cholesterol homeostasis remains to be elucidated, these findings also suggest that low level of hypothalamic PSA might be a risk factor for dyslipidemia and cardiovasc...Continue Reading

References

Apr 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·E R VimrF A Troy
Nov 17, 1994·Biochimica Et Biophysica Acta·J D Sparks, C E Sparks
May 3, 1996·Science·M S Brown, J L Goldstein
Nov 28, 2001·Diabetes·J WangL Rossetti
Sep 10, 2002·American Journal of Physiology. Endocrinology and Metabolism·Bo Ahrén, Giovanni Pacini
Nov 7, 2002·Physiology & Behavior·Lenka FedorkovaJ David Glass
Feb 27, 2004·The Biochemical Journal·Sonya VanpattenDavid E Cohen
Apr 6, 2004·Science·Shirly PintoTamas L Horvath
Oct 4, 2005·Journal of the American College of Cardiology·Peter Libby
Dec 1, 1960·The Journal of Clinical Investigation·C G GunnS O Byers
Sep 22, 2006·Nature·G J MortonM W Schwartz
Sep 22, 2007·The Journal of Clinical Investigation·Ruben NogueirasMatthias H Tschöp
Dec 7, 2007·Nature Reviews. Neuroscience·Urs Rutishauser
Nov 27, 2008·Journal of Lipid Research·Kerry-Anne RyePhilip J Barter
Jan 14, 2009·Nature Reviews. Genetics·Robert A Hegele
Feb 7, 2009·American Journal of Physiology. Gastrointestinal and Liver Physiology·Sandra Jimena Hernández VallejoJean-Marc Lacorte
Feb 5, 2010·The European Journal of Neuroscience·Michelle A BlackKazue Semba
Jun 8, 2010·Nature Neuroscience·Diego Perez-TilveMatthias H Tschöp
Aug 4, 2010·Proceedings of the National Academy of Sciences of the United States of America·Tamas L HorvathMatthias H Tschöp
Feb 16, 2011·Nature Reviews. Cardiology·Ariel Brautbar, Christie M Ballantyne
May 20, 2011·Nature·Peter LibbyGöran K Hansson
May 28, 2011·Trends in Endocrinology and Metabolism : TEM·Sung Hee Choi, Henry N Ginsberg
Jul 8, 2011·Current Opinion in Lipidology·Diego Perez-TilveSusanna M Hofmann
Jul 12, 2011·Progress in Lipid Research·Frank W Pfrieger, Nicole Ungerer
Aug 31, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Alexandre BenaniLuc Pénicaud
Oct 18, 2012·American Journal of Physiology. Endocrinology and Metabolism·Jennifer M RojasKevin D Niswender
Nov 16, 2012·Nature·Martin G Myers, David P Olson

❮ Previous
Next ❯

Citations

Mar 18, 2021·Cell Reports·Irene AnastasiaLuca Pellegrini

❮ Previous
Next ❯

Software Mentioned

Prism
GraphPad

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.